FSE$QGEN

QIAGEN · Q4 2024 earnings

Q4 2024 earnings · · Investor relations

Briefing

QGEN Q4 2024 — CHF 450.9M revenue

For information regarding the effects of currency fluctuations on our results, see "Operating and Financial Review. QIAGEN reported Q4 2024 results. Net income of CHF 83.6M. Headline numbers extracted from the Form 20-F press release; narrative is light because this row was processed without an LLM call.

  • Revenue: CHF 450.9M.
  • Net income: CHF 83.6M.
  • Operating income: CHF 97.7.
  • Gross profit: CHF 967.4.

Headline financials

Total Revenue

$489M

Previous: $473M+3.2%
EPS (adj)

$0.61

Previous: $0.55+10.9%
Capital Expenditures

-$49.9M

Previous: -$49.7M-0.2%
Net Income

$82.8M

Previous: $97.7M-15.2%
Operating Income

$132M

Previous: $134M-1.6%
Gross Profit

$325M

Previous: $345M-5.8%
R&D Expense

$45.6M

Previous: $46M-0.9%

Revenue & EPS history

QIAGEN · Revenue · Quarterly

$489M

Q4 2024+3.2%vs Q4 2023
Beat estimate in 8 of 13 quarters(62%)
ActualEstimate

Revenue by segment

QIAGEN · $847M total across 4 segments · Q1 2026

  • Consumables and related revenues
    $445M
  • Diagnostic solutions
    $185M
  • Sample technologies
    $170M
  • Instruments
    $47.5M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+0.5%

Avg return

Earnings day

+1.4%

Avg return

5 days after

+3.0%

Avg return

30 days after

50%

32 / 64 earnings

Positive

+16.1%

Q2 2016

Best reaction

-6.2%

Q3 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.3%-13.5%-3.8%
Q4 2025-0.9%-1.2%-13.8%
Q3 2025-3.6%-2.2%+6.5%
Q2 2025-3.1%+3.1%+0.1%
Q1 2025+1.7%-0.7%+10.3%
Q4 2024-2.1%-7.6%-8.3%
Q3 2024+0.4%+0.2%-1.2%
Q2 2024+2.4%+0.4%+2.2%
Q1 2024+1.6%+3.2%+2.2%
Q4 2023+3.1%+5.5%+5.5%
Q3 2023+3.7%+8.6%+14.2%
Q2 2023-1.1%-3.3%-6.9%
Q1 2023+3.8%+3.9%+4.8%
Q4 2022+0.1%-0.2%-7.1%
Q3 2022+3.8%+12.9%+14.6%
Q2 2022+1.9%+4.7%+1.0%
Q1 2022+0.3%+0.4%+1.0%
Q4 2021+0.8%-3.1%-11.3%
Q3 2021+0.9%-1.5%-1.7%
Q2 2021+2.3%+1.7%+7.5%
Q1 2021-0.4%-1.0%-2.2%
Q4 2020-1.4%+0.4%-12.9%
Q3 2020-1.1%-3.7%-4.1%
Q2 2020-3.8%-3.3%-4.0%
Q1 2020+1.8%+2.7%+4.9%
Q4 2019+3.8%+5.7%+23.7%
Q3 2019+2.9%+6.1%+47.7%
Q2 2019-1.6%-3.0%-9.8%
Q1 2019-5.5%-5.7%-0.5%
Q4 2018-0.9%-0.3%+6.7%
Q3 2018+4.7%+8.4%+3.0%
Q2 2018+4.1%+5.4%+8.1%
Q1 2018+4.0%+5.0%+11.2%
Q4 2017+0.6%-4.9%-3.2%
Q2 2017-3.4%-4.0%-8.1%
Q1 2017+2.1%+5.6%+11.6%
Q4 2016+1.1%+0.4%+0.9%
Q3 2016+7.6%+12.6%+11.8%
Q2 2016+16.1%+15.8%+15.5%
Q1 2016-4.0%
Q4 2015-2.0%
Q3 2015-6.2%
Q2 2015+2.2%
Q1 2015-0.2%
Q4 2014-1.2%
Q3 2014+1.0%
Q2 2014-0.5%
Q4 2013-3.7%
Q2 2013+1.1%
Q1 2013-3.7%
Q4 2012+6.6%
Q3 2012+3.8%
Q2 2012-0.2%
Q1 2012-0.2%
Q4 2011-1.0%
Q3 2011-1.8%
Q2 2011+1.4%
Q1 2011+1.4%
Q4 2008-0.1%
Q4 2010-0.1%
Q4 2009-0.1%
Q3 2010-1.7%
Q1 2010-1.2%
Q2 2010-1.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro